An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials.

Bibliographic Details
Title: An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials.
Authors: David J Pinato, Chara Stavraka, Michael J Flynn, Martin D Forster, Séan M O'Cathail, Michael J Seckl, Rebecca S Kristeleit, David Olmos, Samantha J Turnbull, Sarah P Blagden
Source: PLoS ONE, Vol 9, Iss 1, p e83279 (2014)
Publisher Information: Public Library of Science (PLoS), 2014.
Publication Year: 2014
Collection: LCC:Medicine
LCC:Science
Subject Terms: Medicine, Science
More Details: Adequate organ function and good performance status (PS) are common eligibility criteria for phase I trials. As inflammation is pathogenic and prognostic in cancer we investigated the prognostic performance of inflammation-based indices including the neutrophil (NLR) and platelet to lymphocyte ratio (PLR).We studied inflammatory scores in 118 unselected referrals. NLR normalization was recalculated at disease reassessment. Each variable was assessed for progression-free (PFS) and overall survival (OS) on uni- and multivariate analyses and tested for 90 days survival (90DS) prediction using receiving operator curves (ROC).We included 118 patients with median OS 4.4 months, 23% PS>1. LDH≥450 and NLR≥5 were multivariate predictors of OS (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1932-6203
Relation: http://europepmc.org/articles/PMC3883636?pdf=render; https://doaj.org/toc/1932-6203
DOI: 10.1371/journal.pone.0083279
Access URL: https://doaj.org/article/2edb1a12d61e4577bf54b5381ef4a2ae
Accession Number: edsdoj.2edb1a12d61e4577bf54b5381ef4a2ae
Database: Directory of Open Access Journals
More Details
ISSN:19326203
DOI:10.1371/journal.pone.0083279
Published in:PLoS ONE
Language:English